{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:39:56Z","timestamp":1791218396578,"version":"4.1.0"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"crossref","award":["#PSO-PHAC-2015-10314-R7"],"award-info":[{"award-number":["#PSO-PHAC-2015-10314-R7"]}],"id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      We conducted systematic reviews on the benefits and harms of screening compared with no screening or alternative screening approaches for\n                      <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                      (CT) and\n                      <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                      (NG) in non-pregnant sexually active individuals, and on the relative importance patients\u2019 place on the relevant outcomes. Findings will inform recommendations by the Canadian Task Force on Preventive Health Care.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched five databases (to January 24, 2020), trial registries, conference proceedings, and reference lists for English and French literature published since 1996. Screening, study selection, and risk of bias assessments were independently undertaken by two reviewers, with consensus for final decisions. Data extraction was conducted by one reviewer and checked by another for accuracy and completeness. Meta-analysis was conducted where appropriate. We used the GRADE approach to rate the certainty of the evidence. The Task Force and content experts provided input on determining thresholds for important effect sizes and on interpretation of findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 41 included studies, 17 and 11 reported on benefits and harms of screening, respectively, and 14 reported on patient preferences. Universal screening for CT in general populations 16 to 29 years of age, using population-based or opportunistic approaches achieving low screening rates, may make little-to-no difference for a female\u2019s risk of pelvic inflammatory disease (PID) (2 RCTs,\n                      <jats:italic>n<\/jats:italic>\n                      =141,362; 0.3 more in 1000 [7.6 fewer to 11 more]) or ectopic pregnancy (1 RCT,\n                      <jats:italic>n<\/jats:italic>\n                      =15,459; 0.20 more per 1000 [2.2 fewer to 3.9 more]). It may also not make a difference for CT transmission (3 RCTs,\n                      <jats:italic>n<\/jats:italic>\n                      =41,709; 3 fewer per 1000 [11.5 fewer to 6.9 more]). However, benefits may be achieved for reducing PID if screening rates are increased (2 trials,\n                      <jats:italic>n<\/jats:italic>\n                      =30,652; 5.7 fewer per 1000 [10.8 fewer to 1.1 more]), and for reducing CT and NG transmission when intensely screening high-prevalence female populations (2 trials,\n                      <jats:italic>n<\/jats:italic>\n                      =6127; 34.3 fewer per 1000 [4 to 58 fewer]; NNS 29 [17 to 250]). Evidence on infertility in females from CT screening and on transmission of NG in males and both sexes from screening for CT and NG is very uncertain. No evidence was found for cervicitis, chronic pelvic pain, or infertility in males from CT screening, or on any clinical outcomes from NG screening. Undergoing screening, or having a diagnosis of CT, may cause a small-to-moderate number of people to experience some degree of harm, mainly due to feelings of stigmatization and anxiety about future infertility risk. The number of individuals affected in the entire screening-eligible population is likely smaller. Screening may make little-to-no difference for general anxiety, self-esteem, or relationship break-up. Evidence on transmission from studies comparing home versus clinic screening is very uncertain. Four studies on patient preferences found that although utility values for the different consequences of CT and NG infections are probably quite similar, when considering the duration of the health state experiences, infertility and chronic pelvic pain are probably valued much more than PID, ectopic pregnancy, and cervicitis. How patients weigh the potential benefits versus harms of screening is very uncertain (1 survey, 10 qualitative studies); risks to reproductive health and transmission appear to be more important than the (often transient) psychosocial\u00a0harms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Most of the evidence on screening for CT and\/or NG offers low or very low certainty about the benefits and harms. Indirectness from use of comparison groups receiving some screening, incomplete outcome ascertainment, and use of outreach settings was a major contributor to uncertainty. Patient preferences indicate that the potential benefits from screening appear to outweigh the possible harms. Direct evidence about which screening strategies and intervals to use, which age to start and stop screening, and whether screening males in addition to females is necessary to prevent clinical outcomes is scarce, and further research in these areas would be informative. Apart from the evidence in this review, information on factors related to equity, acceptability, implementation, cost\/resources, and feasibility will support recommendations made by the Task Force.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      International Prospective Register of Systematic Reviews (PROSPERO), registration number\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42018100733\">CRD42018100733<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-021-01658-w","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T04:31:56Z","timestamp":1618893116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Screening for chlamydia and\/or gonorrhea in primary health care: systematic reviews on effectiveness and patient preferences"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-7229","authenticated-orcid":false,"given":"Jennifer","family":"Pillay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aireen","family":"Wingert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vandermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,19]]},"reference":[{"issue":"2","key":"1658_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.14745\/ccdr.v44i02a03","volume":"44","author":"Y Choudhri","year":"2018","unstructured":"Choudhri Y, Miller J, Sandhu J, Leon A, Aho J. Chlamydia in Canada, 2010-2015. Can Commun Dis Rep. 2018;44(2):49\u201354. https:\/\/doi.org\/10.14745\/ccdr.v44i02a03.","journal-title":"Can Commun Dis Rep."},{"issue":"2","key":"1658_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.14745\/ccdr.v44i02a01","volume":"44","author":"Y Choudhri","year":"2018","unstructured":"Choudhri Y, Miller J, Sandhu J, Leon A, Aho J. Gonorrhea in Canada, 2010-2015. Can Commun Dis Rep. 2018;44(2):37\u201342. https:\/\/doi.org\/10.14745\/ccdr.v44i02a01.","journal-title":"Can Commun Dis Rep."},{"key":"1658_CR3","series-title":"Chlamydia","volume-title":"Notifiable disease chart. Rate per 100,000 of reported cases by age group in Canada, grouped by sex","author":"Public Health Agency of Canada","year":"2017","unstructured":"Public Health Agency of Canada. Notifiable disease chart. Rate per 100,000 of reported cases by age group in Canada, grouped by sex. Chlamydia, 2017. https:\/\/diseases.canada.ca\/notifiable\/. Accessed 11 Sept 2020."},{"key":"1658_CR4","volume-title":"Report on sexually transmitted infections in Canada: 2013-2014","author":"Public Health Agency of Canada","year":"2017","unstructured":"Public Health Agency of Canada. Report on sexually transmitted infections in Canada: 2013-2014. Ottawa: Centre for Communicable Diseases and Infection Control, Infectious Disease Prevention and Control Branch, PHAC; 2017. https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/report-sexually-transmitted-infections-canada-2013-14.html. Accessed 14 Sept 2020"},{"issue":"1","key":"1658_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s12879-015-1280-6","volume":"15","author":"NH Dukers-Muijrers","year":"2015","unstructured":"Dukers-Muijrers NH, Schachter J, van Liere GA, Wolffs PF, Hoebe CJ. What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion. BMC Infect Dis. 2015;15(1):533. https:\/\/doi.org\/10.1186\/s12879-015-1280-6.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1658_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/lgbt.2014.0056","volume":"2","author":"AR Lutz","year":"2015","unstructured":"Lutz AR. Screening for asymptomatic extragenital gonorrhea and chlamydia in men who have sex with men: significance, recommendations, and options for overcoming barriers to testing. LGBT Health. 2015;2(1):27\u201334. https:\/\/doi.org\/10.1089\/lgbt.2014.0056.","journal-title":"LGBT Health."},{"issue":"1","key":"1658_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2334-12-113","volume":"12","author":"D Lewis","year":"2012","unstructured":"Lewis D, Newton DC, Guy RJ, Ali H, Chen MY, Fairley CK, et al. The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis. BMC Infect Dis. 2012;12(1):113. https:\/\/doi.org\/10.1186\/1471-2334-12-113.","journal-title":"BMC Infect Dis."},{"issue":"10156","key":"1658_CR8","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0140-6736(18)31816-6","volume":"392","author":"JS Hocking","year":"2018","unstructured":"Hocking JS, Temple-Smith M, Guy R, Donovan B, Braat S, Law M, et al. Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial. Lancet. 2018;392(10156):1413\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(18)31816-6.","journal-title":"Lancet."},{"key":"1658_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4316","volume":"345","author":"IV van den Broek","year":"2012","unstructured":"van den Broek IV, van Bergen JE, Brouwers EE, Fennema JS, Gotz HM, Hoebe CJ, et al. Effectiveness of yearly, register based screening for chlamydia in the Netherlands: controlled trial with randomised stepped wedge implementation. BMJ. 2012;345:e4316. https:\/\/doi.org\/10.1136\/bmj.e4316.","journal-title":"BMJ."},{"key":"1658_CR10","unstructured":"Statistics Canada. 2013\/14 Canadian Community Health Survey. Table 7. Canadians who used a condom during last sexual intercourse, by age group and sex, household population aged 15 to 49, 2013\/2014. http:\/\/www.statcan.gc.ca\/daily-quotidien\/150624\/t007b-eng.htm. Accessed 11 Sept 2020."},{"issue":"2","key":"1658_CR11","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1783\/147118906776276440","volume":"32","author":"V Lee","year":"2006","unstructured":"Lee V, Tobin JM, Foley E. Relationship of cervical ectopy to chlamydia infection in young women. J Fam Plann Reprod Health Care. 2006;32(2):104\u20136. https:\/\/doi.org\/10.1783\/147118906776276440.","journal-title":"J Fam Plann Reprod Health Care."},{"issue":"Suppl 1","key":"1658_CR12","doi-asserted-by":"publisher","first-page":"i64","DOI":"10.1136\/sti.78.suppl_1.i64","volume":"78","author":"S Hodgins","year":"2002","unstructured":"Hodgins S, Peeling RW, Dery S, Bernier F, LaBrecque A, Proulx JF, et al. The value of mass screening for chlamydia control in high prevalence communities. Sex Transm Infect. 2002;78(Suppl 1):i64\u20138. https:\/\/doi.org\/10.1136\/sti.78.suppl_1.i64.","journal-title":"Sex Transm Infect."},{"key":"1658_CR13","unstructured":"World Health Organization. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people. Recommendations for a public health approach 2011. Geneva; 2011. http:\/\/www.who.int\/hiv\/pub\/guidelines\/msm_guidelines2011\/en\/. Accessed 11 Sept 2020"},{"issue":"2","key":"1658_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1258\/095646203321156872","volume":"14","author":"S Creighton","year":"2003","unstructured":"Creighton S, Tenant-Flowers M, Taylor CB, Miller R, Low N. Co-infection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS. 2003;14(2):109\u201313. https:\/\/doi.org\/10.1258\/095646203321156872.","journal-title":"Int J STD AIDS."},{"issue":"2","key":"1658_CR15","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1155\/2010\/760218","volume":"21","author":"KR Forward","year":"2010","unstructured":"Forward KR. Risk of coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in Nova Scotia. Can J Infect Dis Med Microbiol. 2010;21(2):e84\u20136. https:\/\/doi.org\/10.1155\/2010\/760218.","journal-title":"Can J Infect Dis Med Microbiol."},{"issue":"3","key":"1658_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.7326\/0003-4819-139-3-200308050-00007","volume":"139","author":"SB Lyss","year":"2003","unstructured":"Lyss SB, Kamb ML, Peterman TA, Moran JS, Newman DR, Bolan G, et al. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med. 2003;139(3):178\u201385. https:\/\/doi.org\/10.7326\/0003-4819-139-3-200308050-00007.","journal-title":"Ann Intern Med."},{"issue":"5","key":"1658_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1258\/0956462053888925","volume":"16","author":"A McMillan","year":"2005","unstructured":"McMillan A, Manavi K, Young H. Concurrent gonococcal and chlamydial infections among men attending a sexually transmitted diseases clinic. Int J STD AIDS. 2005;16(5):357\u201361. https:\/\/doi.org\/10.1258\/0956462053888925.","journal-title":"Int J STD AIDS."},{"issue":"8","key":"1658_CR18","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/JCM.00748-12","volume":"50","author":"CC Ginocchio","year":"2012","unstructured":"Ginocchio CC, Chapin K, Smith JS, Aslanzadeh J, Snook J, Hill CS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol. 2012;50(8):2601\u20138. https:\/\/doi.org\/10.1128\/JCM.00748-12.","journal-title":"J Clin Microbiol."},{"issue":"12","key":"1658_CR19","doi-asserted-by":"publisher","first-page":"884","DOI":"10.7326\/M14-1022","volume":"161","author":"B Zakher","year":"2014","unstructured":"Zakher B, Cantor AG, Pappas M, Daeges M, Nelson HD. Screening for gonorrhea and chlamydia: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;161(12):884\u201393. https:\/\/doi.org\/10.7326\/M14-1022.","journal-title":"Ann Intern Med."},{"issue":"1","key":"1658_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/infdis\/jis644","volume":"207","author":"ML Rekart","year":"2013","unstructured":"Rekart ML, Gilbert M, Meza R, Kim PH, Chang M, Money DM, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis. 2013;207(1):30\u20138. https:\/\/doi.org\/10.1093\/infdis\/jis644.","journal-title":"J Infect Dis."},{"issue":"9","key":"1658_CR21","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/sim.5603","volume":"32","author":"MJ Price","year":"2013","unstructured":"Price MJ, Ades AE, Angelis DD, Welton NJ, Macleod J, Soldan K, et al. Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection. Stat Med. 2013;32(9):1547\u201360. https:\/\/doi.org\/10.1002\/sim.5603.","journal-title":"Stat Med."},{"issue":"6","key":"1658_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1093\/infdis\/jiv517","volume":"213","author":"YH Grad","year":"2016","unstructured":"Grad YH, Goldstein E, Lipsitch M, White PJ. Improving control of antibiotic-resistant gonorrhea by integrating research agendas across disciplines: key questions arising from mathematical modeling. J Infect Dis. 2016;213(6):883\u201390. https:\/\/doi.org\/10.1093\/infdis\/jiv517.","journal-title":"J Infect Dis."},{"issue":"S2","key":"1658_CR23","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1086\/652397","volume":"201","author":"T Darville","year":"2010","unstructured":"Darville T, Hiltke TJ. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis. 2010;201(S2):S114\u201325.","journal-title":"J Infect Dis."},{"issue":"8","key":"1658_CR24","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.2105\/AJPH.2014.302044","volume":"104","author":"KA McElligott","year":"2014","unstructured":"McElligott KA. Mortality from sexually transmitted diseases in reproductive-aged women: United States, 1999-2010. Am J Public Health. 2014;104(8):e101\u20135. https:\/\/doi.org\/10.2105\/AJPH.2014.302044.","journal-title":"Am J Public Health."},{"key":"1658_CR25","unstructured":"Pelvic Inflammatory Disease (PID) - CDC Fact Sheet. https:\/\/www.cdc.gov\/std\/pid\/stdfact-pid-detailed.htm. Accessed 11 Sept 2020."},{"issue":"4","key":"1658_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/infdis\/jiw178","volume":"214","author":"MJ Price","year":"2016","unstructured":"Price MJ, Ades AE, Welton NJ, Simms I, Macleod J, Horner PJ. Proportion of pelvic inflammatory disease cases caused by Chlamydia trachomatis: consistent picture from different methods. J Infect Dis. 2016;214(4):617\u201324. https:\/\/doi.org\/10.1093\/infdis\/jiw178.","journal-title":"J Infect Dis."},{"key":"1658_CR27","volume-title":"Chlamydia control in Europe: literature review","author":"European Centre for Disease Prevention and Control","year":"2014","unstructured":"European Centre for Disease Prevention and Control. Chlamydia control in Europe: literature review. Stockholm: ECDC; 2014. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/chlamydia-control-europe-literature-review. Accessed 11 Sept 2020"},{"issue":"apr08 1","key":"1658_CR28","doi-asserted-by":"publisher","first-page":"c1642","DOI":"10.1136\/bmj.c1642","volume":"340","author":"P Oakeshott","year":"2010","unstructured":"Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010;340(apr08 1):c1642. https:\/\/doi.org\/10.1136\/bmj.c1642.","journal-title":"BMJ."},{"issue":"3","key":"1658_CR29","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/aje\/kws583","volume":"178","author":"MJ Price","year":"2013","unstructured":"Price MJ, Ades AE, De Angelis D, Welton NJ, Macleod J, Soldan K, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013;178(3):484\u201392. https:\/\/doi.org\/10.1093\/aje\/kws583.","journal-title":"Am J Epidemiol."},{"issue":"9","key":"1658_CR30","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/OLQ.0b013e31821f918c","volume":"38","author":"M Trent","year":"2011","unstructured":"Trent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis. 2011;38(9):879\u201381. https:\/\/doi.org\/10.1097\/OLQ.0b013e31821f918c.","journal-title":"Sex Transm Dis."},{"issue":"21","key":"1658_CR31","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra1411426","volume":"372","author":"RC Brunham","year":"2015","unstructured":"Brunham RC, Gottlieb SL, Paavonen J. Pelvic inflammatory disease. N Engl J Med. 2015;372(21):2039\u201348. https:\/\/doi.org\/10.1056\/NEJMra1411426.","journal-title":"N Engl J Med."},{"issue":"1","key":"1658_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jval.2013.10.005","volume":"17","author":"LJ Jackson","year":"2014","unstructured":"Jackson LJ, Auguste P, Low N, Roberts TE. Valuing the health states associated with Chlamydia trachomatis infections and their sequelae: a systematic review of economic evaluations and primary studies. Value Health. 2014;17(1):116\u201330. https:\/\/doi.org\/10.1016\/j.jval.2013.10.005.","journal-title":"Value Health."},{"issue":"4","key":"1658_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.euf.2016.08.002","volume":"2","author":"M Fode","year":"2016","unstructured":"Fode M, Fusco F, Lipshultz L, Weidner W. Sexually transmitted disease and male infertility: a systematic review. Eur Urol Focus. 2016;2(4):383\u201393. https:\/\/doi.org\/10.1016\/j.euf.2016.08.002.","journal-title":"Eur Urol Focus."},{"issue":"2","key":"1658_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0956462412472837","volume":"24","author":"C Bignell","year":"2013","unstructured":"Bignell C, Unemo M. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2013;24(2):85\u201392. https:\/\/doi.org\/10.1177\/0956462412472837.","journal-title":"Int J STD AIDS."},{"issue":"1","key":"1658_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/sti.75.1.3","volume":"75","author":"DT Fleming","year":"1999","unstructured":"Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3\u201317. https:\/\/doi.org\/10.1136\/sti.75.1.3.","journal-title":"Sex Transm Infect."},{"key":"1658_CR36","doi-asserted-by":"crossref","unstructured":"Chun HM, Carpenter RJ, Macalino GE, Crum-Cianflone NF. The role of sexually transmitted infections in HIV-1 progression: a comprehensive review of the literature. J Sex Transm Dis. 2013:176459.","DOI":"10.1155\/2013\/176459"},{"issue":"6","key":"1658_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/01.olq.0000154504.54686.d1","volume":"32","author":"J Sexton","year":"2005","unstructured":"Sexton J, Garnett G, Rottingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis. 2005;32(6):351\u20137. https:\/\/doi.org\/10.1097\/01.olq.0000154504.54686.d1.","journal-title":"Sex Transm Dis."},{"key":"1658_CR38","doi-asserted-by":"crossref","unstructured":"Ng BE, Butler LM, Horvath T, Rutherford GW. Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection. Cochrane Database Syst Rev. 2011;(3):CD001220.","DOI":"10.1002\/14651858.CD001220.pub3"},{"issue":"8","key":"1658_CR39","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/OLQ.0b013e3181a2a933","volume":"36","author":"CB Hosenfeld","year":"2009","unstructured":"Hosenfeld CB, Workowski KA, Berman S, Zaidi A, Dyson J, Mosure D, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis. 2009;36(8):478\u201389. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181a2a933.","journal-title":"Sex Transm Dis."},{"issue":"1","key":"1658_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0002-9378(97)80020-8","volume":"176","author":"SD Hillis","year":"1997","unstructured":"Hillis SD, Owens LM, Marchbanks PA, Amsterdam LF, Mac Kenzie WR. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol. 1997;176(1):103\u20137. https:\/\/doi.org\/10.1016\/S0002-9378(97)80020-8.","journal-title":"Am J Obstet Gynecol."},{"issue":"4","key":"1658_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00007435-199207000-00001","volume":"19","author":"L Westrom","year":"1992","unstructured":"Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992;19(4):185\u201392. https:\/\/doi.org\/10.1097\/00007435-199207000-00001.","journal-title":"Sex Transm Dis."},{"issue":"Suppl 8","key":"1658_CR42","doi-asserted-by":"publisher","first-page":"S774","DOI":"10.1093\/cid\/civ694","volume":"61","author":"WM Geisler","year":"2015","unstructured":"Geisler WM. Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2015;61(Suppl 8):S774\u201384. https:\/\/doi.org\/10.1093\/cid\/civ694.","journal-title":"Clin Infect Dis."},{"key":"1658_CR43","doi-asserted-by":"publisher","first-page":"5758387","DOI":"10.1155\/2016\/5758387","volume":"2016","author":"PA Chan","year":"2016","unstructured":"Chan PA, Robinette A, Montgomery M, Almonte A, Cu-Uvin S, Lonks JR, et al. Extragenital infections caused by Chlamydia trachomatis and Neisseria gonorrhoeae: a review of the literature. Infect Dis Obstet Gynecol. 2016;2016:5758387.","journal-title":"Infect Dis Obstet Gynecol."},{"issue":"9","key":"1658_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00007435-200209000-00001","volume":"29","author":"CY Lau","year":"2002","unstructured":"Lau CY, Qureshi AK. Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials. Sex Transm Dis. 2002;29(9):497\u2013502. https:\/\/doi.org\/10.1097\/00007435-200209000-00001.","journal-title":"Sex Transm Dis."},{"key":"1658_CR45","doi-asserted-by":"crossref","unstructured":"Paez-Canro C, Alzate JP, Gonzalez LM, Rubio-Romero JA, Lethaby A, Gaitan HG. Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non-pregnant women. Cochrane Database Syst Rev. 2019;1(1);CD010871.","DOI":"10.1002\/14651858.CD010871.pub2"},{"issue":"Suppl 3","key":"1658_CR46","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1086\/511422","volume":"44","author":"LM Newman","year":"2007","unstructured":"Newman LM, Moran JS, Workowski KA. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis. 2007;44(Suppl 3):S84\u2013101. https:\/\/doi.org\/10.1086\/511422.","journal-title":"Clin Infect Dis."},{"issue":"11","key":"1658_CR47","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/cid\/cit084","volume":"56","author":"LA Barbee","year":"2013","unstructured":"Barbee LA, Kerani RP, Dombrowski JC, Soge OO, Golden MR. A retrospective comparative study of 2-drug oral and intramuscular cephalosporin treatment regimens for pharyngeal gonorrhea. Clin Infect Dis. 2013;56(11):1539\u201345. https:\/\/doi.org\/10.1093\/cid\/cit084.","journal-title":"Clin Infect Dis."},{"issue":"6","key":"1658_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/OLQ.0000000000000280","volume":"42","author":"AE Singh","year":"2015","unstructured":"Singh AE, Gratrix J, Martin I, Friedman DS, Hoang L, Lester R, et al. Gonorrhea treatment failures with oral and injectable expanded spectrum cephalosporin monotherapy vs dual therapy at 4 Canadian sexually transmitted infection clinics, 2010-2013. Sex Transm Dis. 2015;42(6):331\u20136. https:\/\/doi.org\/10.1097\/OLQ.0000000000000280.","journal-title":"Sex Transm Dis."},{"issue":"3","key":"1658_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrurol.2016.268","volume":"14","author":"M Unemo","year":"2017","unstructured":"Unemo M, Jensen JS. Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium. Nat Rev Urol. 2017;14(3):139\u201352. https:\/\/doi.org\/10.1038\/nrurol.2016.268.","journal-title":"Nat Rev Urol."},{"issue":"66","key":"1658_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1098\/rsif.2011.0131","volume":"9","author":"CL Althaus","year":"2012","unstructured":"Althaus CL, Turner KM, Schmid BV, Heijne JC, Kretzschmar M, Low N. Transmission of Chlamydia trachomatis through sexual partnerships: a comparison between three individual-based models and empirical data. J R Soc Interface. 2012;9(66):136\u201346. https:\/\/doi.org\/10.1098\/rsif.2011.0131.","journal-title":"J R Soc Interface."},{"issue":"3","key":"1658_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1071\/SH12069","volume":"10","author":"S Gudka","year":"2013","unstructured":"Gudka S, Afuwape FE, Wong B, Yow XL, Anderson C, Clifford RM. Chlamydia screening interventions from community pharmacies: a systematic review. Sex Health. 2013;10(3):229\u201339. https:\/\/doi.org\/10.1071\/SH12069.","journal-title":"Sex Health."},{"issue":"2","key":"1658_CR52","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jemermed.2012.08.022","volume":"44","author":"WD Jenkins","year":"2013","unstructured":"Jenkins WD, Zahnd W, Kovach R, Kissinger P. Chlamydia and gonorrhea screening in United States emergency departments. J Emerg Med. 2013;44(2):558\u201367. https:\/\/doi.org\/10.1016\/j.jemermed.2012.08.022.","journal-title":"J Emerg Med."},{"issue":"1","key":"1658_CR53","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1186\/1471-2458-13-1040","volume":"13","author":"B Hengel","year":"2013","unstructured":"Hengel B, Jamil MS, Mein JK, Maher L, Kaldor JM, Guy RJ. Outreach for chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes. BMC Public Health. 2013;13(1):1040. https:\/\/doi.org\/10.1186\/1471-2458-13-1040.","journal-title":"BMC Public Health."},{"issue":"3","key":"1658_CR54","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/OLQ.0000000000000095","volume":"41","author":"MS Jamil","year":"2014","unstructured":"Jamil MS, Bauer HM, Hocking JS, Ali H, Wand H, Walker J, et al. Chlamydia screening strategies and outcomes in educational settings: a systematic review. Sex Transm Dis. 2014;41(3):180\u20137. https:\/\/doi.org\/10.1097\/OLQ.0000000000000095.","journal-title":"Sex Transm Dis."},{"issue":"1","key":"1658_CR55","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1471-2458-13-189","volume":"13","author":"MS Jamil","year":"2013","unstructured":"Jamil MS, Hocking JS, Bauer HM, Ali H, Wand H, Smith K, et al. Home-based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes. BMC Public Health. 2013;13(1):189. https:\/\/doi.org\/10.1186\/1471-2458-13-189.","journal-title":"BMC Public Health."},{"issue":"7","key":"1658_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132776","volume":"10","author":"C Lunny","year":"2015","unstructured":"Lunny C, Taylor D, Hoang L, Wong T, Gilbert M, Lester R, et al. Self-collected versus clinician-collected sampling for chlamydia and gonorrhea screening: a systemic review and meta-analysis. PLoS ONE. 2015;10(7):e0132776. https:\/\/doi.org\/10.1371\/journal.pone.0132776.","journal-title":"PLoS ONE."},{"key":"1658_CR57","first-page":"869","volume":"61","author":"L Pogany","year":"2015","unstructured":"Pogany L, Romanowski B, Robinson J, Gale-Rowe M, Latham-Carmanico C, Weir C, et al. Management of gonococcal infection among adults and youth: new key recommendations. Can Fam Physician. 2015;61:869\u201373, e451-6.","journal-title":"Can Fam Physician."},{"key":"1658_CR58","unstructured":"Public Health Agency of Canada. Canadian Guidelines on Sexually Transmitted Infections. https:\/\/www.canada.ca\/en\/public-health\/services\/infectious-diseases\/sexual-health-sexually-transmitted-infections\/canadian-guidelines\/sexually-transmitted-infections.html. Accessed 11 Sept 2020."},{"issue":"2","key":"1658_CR59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/sti.2010.042192","volume":"87","author":"B Andersen","year":"2011","unstructured":"Andersen B, van Valkengoed I, Sokolowski I, Moller JK, Ostergaard L, Olesen F. Impact of intensified testing for urogenital Chlamydia trachomatis infections: a randomised study with 9-year follow-up. Sex Transm Infect. 2011;87(2):156\u201361. https:\/\/doi.org\/10.1136\/sti.2010.042192.","journal-title":"Sex Transm Infect."},{"issue":"9821","key":"1658_CR60","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S0140-6736(11)61846-1","volume":"379","author":"PJ Garcia","year":"2012","unstructured":"Garcia PJ, Holmes KK, Carcamo CP, Garnett GP, Hughes JP, Campos PE, et al. Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial. Lancet. 2012;379(9821):1120\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(11)61846-1.","journal-title":"Lancet."},{"key":"1658_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jclinepi.2018.01.013","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Alonso-Coello P, Guyatt GH, Yepes-Nunez JJ, Akl EA, Hazlewood G, et al. GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-risk of bias and indirectness. J Clin Epidemiol. 2019;111:94\u2013104. https:\/\/doi.org\/10.1016\/j.jclinepi.2018.01.013.","journal-title":"J Clin Epidemiol."},{"issue":"1","key":"1658_CR62","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12955-017-0621-0","volume":"15","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Coello PA, Brozek J, Wiercioch W, Etxeandia-Ikobaltzeta I, Akl EA, et al. Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach. Health Qual Life Outcomes. 2017;15(1):52. https:\/\/doi.org\/10.1186\/s12955-017-0621-0.","journal-title":"Health Qual Life Outcomes."},{"key":"1658_CR63","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jclinepi.2018.05.011","volume":"111","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Coello PA, Guyatt GH, Yepes-Nunez JJ, Akl EA, Hazlewood G, et al. GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences-inconsistency, imprecision, and other domains. J Clin Epidemiol. 2019;111:83\u201393. https:\/\/doi.org\/10.1016\/j.jclinepi.2018.05.011.","journal-title":"J Clin Epidemiol."},{"key":"1658_CR64","volume-title":"GRADE handbook","author":"H Schunemann","year":"2013","unstructured":"Schunemann H, Brozek J, Guyatt G, Oxman A: GRADE handbook. 2013. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. Accessed 14 Sept 2020."},{"key":"1658_CR65","volume":"9","author":"N Low","year":"2016","unstructured":"Low N, Redmond S, Uuskula A, van Bergen J, Ward H, Andersen B, et al. Screening for genital chlamydia infection. Cochrane Database Syst Rev. 2016;9:CD010866.","journal-title":"Cochrane Database Syst Rev."},{"issue":"1","key":"1658_CR66","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13643-018-0904-5","volume":"7","author":"J Pillay","year":"2018","unstructured":"Pillay J, Moore A, Rahman P, Lewin G, Reynolds D, Riva J, et al. Screening for chlamydia and\/or gonorrhea in primary health care: protocol for systematic review. Syst Rev. 2018;7(1):248. https:\/\/doi.org\/10.1186\/s13643-018-0904-5.","journal-title":"Syst Rev."},{"issue":"7","key":"1658_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med."},{"key":"1658_CR68","volume-title":"Human Development Reports: Human Development Index (HDI) Ranking 2018","author":"United Nations Development Programme","year":"2018","unstructured":"United Nations Development Programme. Human Development Reports: Human Development Index (HDI) Ranking 2018. New York: United Nations Development Programme; 2018. http:\/\/hdr.undp.org\/en\/2018-update . Accessed 11 Sept 2020"},{"issue":"4","key":"1658_CR69","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1177\/1090198114568308","volume":"42","author":"JR Glassman","year":"2015","unstructured":"Glassman JR, Potter SC, Baumler ER, Coyle KK. Estimates of intraclass correlation coefficients from longitudinal group-randomized trials of adolescent HIV\/STI\/pregnancy prevention programs. Health Educ Behav. 2015;42(4):545\u201353. https:\/\/doi.org\/10.1177\/1090198114568308.","journal-title":"Health Educ Behav."},{"key":"1658_CR70","volume-title":"GRADE handbook: 4.3 summary of findings table","author":"H Schunemann","year":"2013","unstructured":"Schunemann H, Brozek J, Guyatt G, Oxman A: GRADE handbook: 4.3 summary of findings table. 2013. http:\/\/gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html. Accessed 14 Sept 2020."},{"key":"1658_CR71","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629-34. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"1658_CR72","volume-title":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0","author":"J Higgins","year":"2011","unstructured":"Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. 2011. http:\/\/training.cochrane.org\/handbook. Accessed 11 Sept 2020."},{"key":"1658_CR73","unstructured":"National Institute for Health and Care Excellence: Appendix D methodology checklist: cohort studies. The social care guidance manual. PMG10. 2016. https:\/\/www.nice.org.uk\/process\/pmg10\/chapter\/appendix-d-methodology-checklist-cohort-studies#checklist-3. Accessed 11 Sept 2020."},{"key":"1658_CR74","unstructured":"Wells GA, Shea B, O'Connell D, Petersen J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Canada: Department of Epidemiology and Community Medicine, University of Ottawa. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 11 Sept 2020"},{"key":"1658_CR75","volume-title":"Appraisal of a cross-sectional study (survey)","author":"Centre for Evidence-Based Management (CEBMa)","year":"2018","unstructured":"Centre for Evidence-Based Management (CEBMa). Appraisal of a cross-sectional study (survey). Leiden: The Netherlands; 2018. https:\/\/www.cebma.org\/resources-and-tools\/what-is-critical-appraisal\/. Accessed 11 Sept 2020"},{"key":"1658_CR76","volume-title":"CASP qualitative checklist","author":"Critical Appraisal Skills Programme","year":"2018","unstructured":"Critical Appraisal Skills Programme. CASP qualitative checklist. Oxford: Middleway; 2018. https:\/\/casp-uk.net\/casp-tools-checklists\/. Accessed 11 Sept 2020"},{"issue":"4","key":"1658_CR77","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Schunemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380\u20132. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.09.011.","journal-title":"J Clin Epidemiol."},{"key":"1658_CR78","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","volume":"87","author":"M Hultcrantz","year":"2017","unstructured":"Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, et al. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017;87:4\u201313. https:\/\/doi.org\/10.1016\/j.jclinepi.2017.05.006.","journal-title":"J Clin Epidemiol."},{"issue":"3","key":"1658_CR79","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1136\/ebmed-2017-110668","volume":"22","author":"MH Murad","year":"2017","unstructured":"Murad MH, Mustafa RA, Schunemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evid Based Med. 2017;22(3):85\u20137. https:\/\/doi.org\/10.1136\/ebmed-2017-110668.","journal-title":"Evid Based Med."},{"key":"1658_CR80","doi-asserted-by":"crossref","unstructured":"Santesso N, Glenton C, Dahm P, Garner P, Akl E, Alper B, et al. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126\u201335.","DOI":"10.1016\/j.jclinepi.2019.10.014"},{"issue":"6","key":"1658_CR81","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/sextrans-2017-053229","volume":"94","author":"N Andersson","year":"2018","unstructured":"Andersson N, Carre H, Janlert U, Boman J, Nylander E. Gender differences in the well-being of patients diagnosed with Chlamydia trachomatis: a cross-sectional study. Sex Transm Infect. 2018;94(6):401\u20135. https:\/\/doi.org\/10.1136\/sextrans-2017-053229.","journal-title":"Sex Transm Infect."},{"issue":"1","key":"1658_CR82","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/1471-2458-10-425","volume":"10","author":"M Balfe","year":"2010","unstructured":"Balfe M, Brugha R, O\u2019Donovan D, O'Connell E, Vaughan D. Young women\u2019s decisions to accept chlamydia screening: influences of stigma and doctor-patient interactions. BMC Public Health. 2010;10(1):425. https:\/\/doi.org\/10.1186\/1471-2458-10-425.","journal-title":"BMC Public Health."},{"issue":"4","key":"1658_CR83","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/07448480209596021","volume":"50","author":"KR Barth","year":"2002","unstructured":"Barth KR, Cook RL, Downs JS, Switzer GE, Fischhoff B. Social stigma and negative consequences: factors that influence college students\u2019 decisions to seek testing for sexually transmitted infections. J Am Coll Health. 2002;50(4):153\u20139. https:\/\/doi.org\/10.1080\/07448480209596021.","journal-title":"J Am Coll Health."},{"key":"1658_CR84","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/pubmed\/fds082","volume":"35","author":"AR Booth","year":"2013","unstructured":"Booth AR, Harris PR, Goyder E, Norman P. Beliefs about chlamydia testing amongst young people living in relatively deprived areas. J Public Health (Oxf). 2013;35:213\u201322.","journal-title":"J Public Health (Oxf)"},{"issue":"9","key":"1658_CR85","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/1359105313510335","volume":"20","author":"AR Booth","year":"2015","unstructured":"Booth AR, Norman P, Harris PR, Goyder E. Using the Theory of Planned Behavior to identify key beliefs underlying chlamydia testing intentions in a sample of young people living in deprived areas. J Health Psychol. 2015;20(9):1229\u201339. https:\/\/doi.org\/10.1177\/1359105313510335.","journal-title":"J Health Psychol."},{"key":"1658_CR86","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1471-2458-6-106","volume":"6","author":"R Campbell","year":"2006","unstructured":"Campbell R, Mills N, Sanford E, Graham A, Low N, Peters TJ, et al. Does population screening for Chlamydia trachomatis raise anxiety among those tested? Findings from a population based chlamydia screening study. BMC Public Health. 2006;6:106.","journal-title":"BMC Public Health"},{"issue":"4","key":"1658_CR87","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jpag.2007.08.009","volume":"21","author":"MR Chacko","year":"2008","unstructured":"Chacko MR, von Sternberg K, Velasquez MM, Wiemann CM, Smith PB, DiClemente R. Young women\u2019s perspective of the pros and cons to seeking screening for chlamydia and gonorrhea: an exploratory study. J Pediatr Adolesc Gynecol. 2008;21(4):187\u201393. https:\/\/doi.org\/10.1016\/j.jpag.2007.08.009.","journal-title":"J Pediatr Adolesc Gynecol."},{"issue":"1","key":"1658_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00007435-200201000-00001","volume":"29","author":"KL Clark","year":"2002","unstructured":"Clark KL, Howell MR, Li Y, Powers T, McKee KT Jr, Quinn TC, et al. Hospitalization rates in female US Army recruits associated with a screening program for Chlamydia trachomatis. Sex Transm Dis. 2002;29(1):1\u20135. https:\/\/doi.org\/10.1097\/00007435-200201000-00001.","journal-title":"Sex Transm Dis."},{"issue":"6","key":"1658_CR89","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1542\/peds.104.6.1281","volume":"104","author":"DA Cohen","year":"1999","unstructured":"Cohen DA, Nsuami M, Martin DH, Farley TA. Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents. Pediatrics. 1999;104(6):1281\u20135. https:\/\/doi.org\/10.1542\/peds.104.6.1281.","journal-title":"Pediatrics."},{"issue":"4","key":"1658_CR90","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1136\/sti.2006.023762","volume":"83","author":"RL Cook","year":"2007","unstructured":"Cook RL, Ostergaard L, Hillier SL, Murray PJ, Chang CC, Comer DM, et al. Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect. 2007;83(4):286\u201391. https:\/\/doi.org\/10.1136\/sti.2006.023762.","journal-title":"Sex Transm Infect."},{"issue":"7280","key":"1658_CR91","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/bmj.322.7280.195","volume":"322","author":"B Duncan","year":"2001","unstructured":"Duncan B, Hart G, Scoular A, Bigrigg A. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ. 2001;322(7280):195\u20139. https:\/\/doi.org\/10.1136\/bmj.322.7280.195.","journal-title":"BMJ."},{"issue":"1","key":"1658_CR92","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/07448481.2012.750610","volume":"61","author":"RL Fielder","year":"2013","unstructured":"Fielder RL, Carey KB, Carey MP. Acceptability of sexually transmitted infection testing using self-collected vaginal swabs among college women. J Am Coll Health. 2013;61(1):46\u201353. https:\/\/doi.org\/10.1080\/07448481.2012.750610.","journal-title":"J Am Coll Health."},{"key":"1658_CR93","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1136\/bmj.322.7296.1245","volume":"322","author":"C France","year":"2001","unstructured":"France C, Thomas K, Slack R, James N. Psychosocial impacts of chlamydia testing are important. BMJ. 2001;322:1245.","journal-title":"BMJ."},{"issue":"11","key":"1658_CR94","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/OLQ.0b013e31822b0bed","volume":"38","author":"SL Gottlieb","year":"2011","unstructured":"Gottlieb SL, Stoner BP, Zaidi AA, Buckel C, Tran M, Leichliter JS, et al. A prospective study of the psychosocial impact of a positive Chlamydia trachomatis laboratory test. Sex Transm Dis. 2011;38(11):1004\u201311. https:\/\/doi.org\/10.1097\/OLQ.0b013e31822b0bed.","journal-title":"Sex Transm Dis."},{"issue":"9","key":"1658_CR95","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/01.olq.0000175416.15905.db","volume":"32","author":"HM Gotz","year":"2005","unstructured":"Gotz HM, Veldhuijzen IK, van Bergen JE, Hoebe CJ, de Zwart O, Richardus JH, et al. Acceptability and consequences of screening for Chlamydia trachomatis by home-based urine testing. Sex Transm Dis. 2005;32(9):557\u201362. https:\/\/doi.org\/10.1097\/01.olq.0000175416.15905.db.","journal-title":"Sex Transm Dis."},{"key":"1658_CR96","volume-title":"Vaccines for the 21st century: a tool for decisionmaking. The National Academies Collection: Reports funded by National Institutes of Health","author":"KR Stratton","year":"2000","unstructured":"Stratton KR, Durch JS, Lawrence RS. Vaccines for the 21st century: a tool for decisionmaking. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC): National Academies Press (US); 2000. http:\/\/nationalacademies.org\/hmd\/Reports\/1999\/Vaccines-for-the-21st-Century-A-Tool-for-Decisionmaking.aspx. Accessed 11 Sept 2020"},{"issue":"529","key":"1658_CR97","first-page":"587","volume":"56","author":"I Kangas","year":"2006","unstructured":"Kangas I, Andersen B, Olesen F, Moller JK, Ostergaard L. Psychosocial impact of Chlamydia trachomatis testing in general practice. Br J Gen Pract. 2006;56(529):587\u201393.","journal-title":"Br J Gen Pract."},{"issue":"1","key":"1658_CR98","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2334-13-30","volume":"13","author":"H Klovstad","year":"2013","unstructured":"Klovstad H, Natas O, Tverdal A, Aavitsland P. Systematic screening with information and home sampling for genital Chlamydia trachomatis infections in young men and women in Norway: a randomized controlled trial. BMC Infect Dis. 2013;13(1):30. https:\/\/doi.org\/10.1186\/1471-2334-13-30.","journal-title":"BMC Infect Dis."},{"issue":"3","key":"1658_CR99","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1097\/01.AOG.0000279153.56275.b5","volume":"110","author":"M Kuppermann","year":"2007","unstructured":"Kuppermann M, Learman LA, Schembri M, Gregorich S, Jacoby A, Jackson RA, et al. Effect of noncancerous pelvic problems on health-related quality of life and sexual functioning. Obstet Gynecol. 2007;110(3):633\u201342. https:\/\/doi.org\/10.1097\/01.AOG.0000279153.56275.b5.","journal-title":"Obstet Gynecol."},{"issue":"12","key":"1658_CR100","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1258\/095646203322556174","volume":"14","author":"N Low","year":"2003","unstructured":"Low N, Connell P, McKevitt C, Baggili T, Tenant-Flowers M, More C, et al. \u2018You can\u2019t tell by looking\u2019: pilot study of a community-based intervention to detect asymptomatic sexually transmitted infections. Int J STD AIDS. 2003;14(12):830\u20134. https:\/\/doi.org\/10.1258\/095646203322556174.","journal-title":"Int J STD AIDS."},{"issue":"3","key":"1658_CR101","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1136\/sti.2005.017186","volume":"82","author":"N Low","year":"2006","unstructured":"Low N, Egger M, Sterne JA, Harbord RM, Ibrahim F, Lindblom B, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women\u2019s Cohort Study. Sex Transm Infect. 2006;82(3):212\u20138. https:\/\/doi.org\/10.1136\/sti.2005.017186.","journal-title":"Sex Transm Infect."},{"issue":"5","key":"1658_CR102","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/fampra\/cml031","volume":"23","author":"N Mills","year":"2006","unstructured":"Mills N, Daker-White G, Graham A, Campbell R. Population screening for Chlamydia trachomatis infection in the UK: a qualitative study of the experiences of those screened. Fam Pract. 2006;23(5):550\u20137. https:\/\/doi.org\/10.1093\/fampra\/cml031.","journal-title":"Fam Pract."},{"issue":"1","key":"1658_CR103","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12913-017-2681-6","volume":"17","author":"A Nielsen","year":"2017","unstructured":"Nielsen A, De Costa A, Danielsson KG, Salazar M. Repeat testing for chlamydia trachomatis, a \u201csafe approach\u201d to unsafe sex? A qualitative exploration among youth in Stockholm. BMC Health Serv Res. 2017;17(1):730. https:\/\/doi.org\/10.1186\/s12913-017-2681-6.","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"1658_CR104","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0956462413482422","volume":"24","author":"N O'Farrell","year":"2013","unstructured":"O'Farrell N, Weiss HA. Effect of chlamydia diagnosis on heterosexual relationships. Int J STD AIDS. 2013;24(9):722\u20136. https:\/\/doi.org\/10.1177\/0956462413482422.","journal-title":"Int J STD AIDS."},{"issue":"4","key":"1658_CR105","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1086\/318139","volume":"31","author":"L Ostergaard","year":"2000","unstructured":"Ostergaard L, Andersen B, Moller JK, Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis. 2000;31(4):951\u20137. https:\/\/doi.org\/10.1086\/318139.","journal-title":"Clin Infect Dis."},{"issue":"11","key":"1658_CR106","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1097\/OLQ.0b013e3182649165","volume":"39","author":"MM Reagan","year":"2012","unstructured":"Reagan MM, Xu H, Shih SL, Secura GM, Peipert JF. A randomized trial of home versus clinic-based sexually transmitted disease screening among men. Sex Transm Dis. 2012;39(11):842\u20137. https:\/\/doi.org\/10.1097\/OLQ.0b013e3182649165.","journal-title":"Sex Transm Dis."},{"key":"1658_CR107","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.annemergmed.2017.04.017","volume":"70","author":"JL Reed","year":"2017","unstructured":"Reed JL, Punches BE, Taylor RG, Macaluso M, Alessandrini EA, Kahn JA. A qualitative analysis of adolescent and caregiver acceptability of universally offered gonorrhea and chlamydia screening in the pediatric emergency department. Ann Emerg Med. 2017;70:787\u201396.e2.","journal-title":"Ann Emerg Med"},{"issue":"21","key":"1658_CR108","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJM199605233342103","volume":"334","author":"D Scholes","year":"1996","unstructured":"Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334(21):1362\u20136. https:\/\/doi.org\/10.1056\/NEJM199605233342103.","journal-title":"N Engl J Med."},{"issue":"3","key":"1658_CR109","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/jech.2004.021584","volume":"59","author":"A Senok","year":"2005","unstructured":"Senok A, Wilson P, Reid M, Scoular A, Craig N, McConnachie A, et al. Can we evaluate population screening strategies in UK general practice? A pilot randomised controlled trial comparing postal and opportunistic screening for genital chlamydial infection. J Epidemiol Community Health. 2005;59(3):198\u2013204. https:\/\/doi.org\/10.1136\/jech.2004.021584.","journal-title":"J Epidemiol Community Health."},{"issue":"3","key":"1658_CR110","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/OLQ.0b013e31815b07dd","volume":"35","author":"KJ Smith","year":"2008","unstructured":"Smith KJ, Tsevat J, Ness RB, Wiesenfeld HC, Roberts MS. Quality of life utilities for pelvic inflammatory disease health states. Sex Transm Dis. 2008;35(3):307\u201311. https:\/\/doi.org\/10.1097\/OLQ.0b013e31815b07dd.","journal-title":"Sex Transm Dis."},{"issue":"6","key":"1658_CR111","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1097\/AOG.0b013e318273364c","volume":"120","author":"CB Sufrin","year":"2012","unstructured":"Sufrin CB, Postlethwaite D, Armstrong MA, Merchant M, Wendt JM, Steinauer JE. Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease. Obstet Gynecol. 2012;120(6):1314\u201321. https:\/\/doi.org\/10.1097\/AOG.0b013e318273364c.","journal-title":"Obstet Gynecol."},{"issue":"1","key":"1658_CR112","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12889-015-2020-y","volume":"15","author":"KA Theunissen","year":"2015","unstructured":"Theunissen KA, Bos AE, Hoebe CJ, Kok G, Vluggen S, Crutzen R, et al. Chlamydia trachomatis testing among young people: what is the role of stigma? BMC Public Health. 2015;15(1):651. https:\/\/doi.org\/10.1186\/s12889-015-2020-y.","journal-title":"BMC Public Health."},{"issue":"7","key":"1658_CR113","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1136\/sextrans-2011-050187","volume":"87","author":"M Trent","year":"2011","unstructured":"Trent M, Lehmann HP, Qian Q, Thompson CB, Ellen JM, Frick KD. Adolescent and parental utilities for the health states associated with pelvic inflammatory disease. Sex Transm Infect. 2011;87(7):583\u20137. https:\/\/doi.org\/10.1136\/sextrans-2011-050187.","journal-title":"Sex Transm Infect."},{"issue":"1","key":"1658_CR114","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1071\/SH12019","volume":"10","author":"J Walker","year":"2013","unstructured":"Walker J, Walker S, Fairley CK, Bilardi J, Chen MY, Bradshaw CS, et al. What do young women think about having a chlamydia test? Views of women who tested positive compared with women who tested negative. Sex Health. 2013;10(1):39\u201342. https:\/\/doi.org\/10.1071\/SH12019.","journal-title":"Sex Health."},{"issue":"12","key":"1658_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002479","volume":"14","author":"E Wilson","year":"2017","unstructured":"Wilson E, Free C, Morris TP, Syred J, Ahamed I, Menon-Johansson AS, et al. Internet-accessed sexually transmitted infection (e-STI) testing and results service: a randomised, single-blind, controlled trial. PLoS Med. 2017;14(12):e1002479. https:\/\/doi.org\/10.1371\/journal.pmed.1002479.","journal-title":"PLoS Med."},{"issue":"11","key":"1658_CR116","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1056\/NEJM199809103391105","volume":"339","author":"CA Gaydos","year":"1998","unstructured":"Gaydos CA, Howell MR, Pare B, Clark KL, Ellis DA, Hendrix RM, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med. 1998;339(11):739\u201344. https:\/\/doi.org\/10.1056\/NEJM199809103391105.","journal-title":"N Engl J Med."},{"issue":"7150","key":"1658_CR117","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1136\/bmj.317.7150.26","volume":"317","author":"L Ostergaard","year":"1998","unstructured":"Ostergaard L, Andersen B, Olesen F, Moller JK. Efficacy of home sampling for screening of Chlamydia trachomatis: randomised study. BMJ. 1998;317(7150):26\u20137. https:\/\/doi.org\/10.1136\/bmj.317.7150.26.","journal-title":"BMJ."},{"issue":"2","key":"1658_CR118","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.contraception.2010.04.037","volume":"82","author":"C Sufrin","year":"2010","unstructured":"Sufrin C, Postlethwaite D, Armstrong MA, Merchant M, Wendt J, Steinauer J. Comparison of the incidence of pelvic inflammatory disease in intrauterine devices users by gonorrhea and chlamydia screening strategies. Contraception. 2010;82(2):186. https:\/\/doi.org\/10.1016\/j.contraception.2010.04.037.","journal-title":"Contraception."},{"issue":"6","key":"1658_CR119","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/0272989X04271042","volume":"24","author":"M Locadia","year":"2004","unstructured":"Locadia M, Stalmeier PF, Oort FJ, Prins MH, Sprangers MA, Bossuyt PM. A comparison of 3 valuation methods for temporary health states in patients treated with oral anticoagulants. Med Decis Making. 2004;24(6):625\u201333. https:\/\/doi.org\/10.1177\/0272989X04271042.","journal-title":"Med Decis Making."},{"issue":"4","key":"1658_CR120","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1370\/afm.2097","volume":"15","author":"MS Naimer","year":"2017","unstructured":"Naimer MS, Kwong JC, Bhatia D, Moineddin R, Whelan M, Campitelli MA, et al. The effect of changes in cervical cancer screening guidelines on chlamydia testing. Ann Fam Med. 2017;15(4):329\u201334. https:\/\/doi.org\/10.1370\/afm.2097.","journal-title":"Ann Fam Med."},{"issue":"10","key":"1658_CR121","first-page":"e459","volume":"61","author":"T Bogler","year":"2015","unstructured":"Bogler T, Farber A, Stall N, Wijayasinghe S, Slater M, Guiang C, et al. Missed connections: unintended consequences of updated cervical cancer screening guidelines on screening rates for sexually transmitted infections. Can Fam Physician. 2015;61(10):e459\u201366.","journal-title":"Can Fam Physician."},{"key":"1658_CR122","doi-asserted-by":"publisher","first-page":"112.e1","DOI":"10.5694\/mja15.00933","volume":"204","author":"A Lau","year":"2016","unstructured":"Lau A, Spark S, Tomnay J, Smith MT, Fairley CK, Guy RJ, et al. Socio-demographic and structural barriers to being tested for chlamydia in general practice. Med J Aust. 2016;204:112.e1\u20135.","journal-title":"Med J Aust"},{"key":"1658_CR123","doi-asserted-by":"publisher","first-page":"A144","DOI":"10.1136\/sextrans-2015-052270.377","volume":"91","author":"C Moreira","year":"2015","unstructured":"Moreira C, Van Gemert C, Hocking JS, Lim MS, Bateson D, McNamee K, et al. Screening for chlamydia concurrently with a routine pap test in primary care: could cervical screening changes impact on chlamydia testing? Sex Transm Infect. 2015;91:A144.","journal-title":"Sex Transm Infect."},{"key":"1658_CR124","first-page":"28","volume":"28","author":"A Yeung","year":"2018","unstructured":"Yeung A, Hocking J, Guy R, Fairley CK, Smith K, Vaisey A, et al. \u2018It Opened My Eyes\u2019-examining the impact of a multifaceted chlamydia testing intervention on general practitioners using Normalization Process Theory. Fam Pract. 2018;28:28.","journal-title":"Fam Pract."},{"key":"1658_CR125","doi-asserted-by":"publisher","first-page":"iii-iv, ix-xii","DOI":"10.3310\/hta11080","volume":"11","author":"N Low","year":"2007","unstructured":"Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, et al. Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. Health Technol Assess. 2007;11:iii-iv, ix-xii 1-165.","journal-title":"Health Technol Assess"},{"issue":"3","key":"1658_CR126","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/oxfordjournals.aje.a008926","volume":"144","author":"M Kretzschmar","year":"1996","unstructured":"Kretzschmar M, van Duynhoven YT, Severijnen AJ. Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations. Am J Epidemiol. 1996;144(3):306\u201317. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a008926.","journal-title":"Am J Epidemiol."},{"issue":"1","key":"1658_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1742-4682-3-3","volume":"3","author":"KM Turner","year":"2006","unstructured":"Turner KM, Adams EJ, Gay N, Ghani AC, Mercer C, Edmunds WJ. Developing a realistic sexual network model of chlamydia transmission in Britain. Theor Biol Med Model. 2006;3(1):3. https:\/\/doi.org\/10.1186\/1742-4682-3-3.","journal-title":"Theor Biol Med Model."},{"key":"1658_CR128","doi-asserted-by":"crossref","unstructured":"Fajardo-Bernal L, Aponte-Gonzalez J, Vigil P, Angel-Muller E, Rincon C, Gaitan HG, et al. Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections. Cochrane Database Syst Rev. 2015;(9):CD011317.","DOI":"10.1002\/14651858.CD011317.pub2"},{"issue":"6","key":"1658_CR129","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1071\/SH13029","volume":"10","author":"TY Odesanmi","year":"2013","unstructured":"Odesanmi TY, Wasti SP, Odesanmi OS, Adegbola O, Oguntuase OO, Mahmood S. Comparative effectiveness and acceptability of home-based and clinic-based sampling methods for sexually transmissible infections screening in females aged 14-50 years: a systematic review and meta-analysis. Sex Health. 2013;10(6):559\u201369. https:\/\/doi.org\/10.1071\/SH13029.","journal-title":"Sex Health."},{"issue":"9","key":"1658_CR130","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S0895-4356(00)00188-8","volume":"53","author":"D Moher","year":"2000","unstructured":"Moher D, Pham B, Klassen TP, Schulz KF, Berlin JA, Jadad AR, et al. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol. 2000;53(9):964\u201372. https:\/\/doi.org\/10.1016\/S0895-4356(00)00188-8.","journal-title":"J Clin Epidemiol."},{"issue":"2","key":"1658_CR131","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1017\/S0266462312000086","volume":"28","author":"A Morrison","year":"2012","unstructured":"Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28(2):138\u201344. https:\/\/doi.org\/10.1017\/S0266462312000086.","journal-title":"Int J Technol Assess Health Care."}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01658-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-021-01658-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-021-01658-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T04:45:15Z","timestamp":1618893915000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-021-01658-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,19]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1658"],"URL":"https:\/\/doi.org\/10.1186\/s13643-021-01658-w","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,19]]},"assertion":[{"value":"23 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}